Nov. 16 at 3:46 PM
$OSCR Oscar Health (NASDAQ:OSCR) projects strong revenue growth through 2028, driven by ACA expansion, AI-driven plans, and its +Oscar full-stack platform. With an earnings swing from –
$161.2M to +
$245.4M, OSCR could be one of the most undervalued tech-enabled insurers today. https://biotechhealthx.com/biotech-news/why-analysts-believe-oscar-health-oscr-could-become-a-12b-plus-digital-insurance-powerhouse/